[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit ::
Main Menu
Home::
Journal Information::
Articles Archive::
Guide for Authors::
For Reviewers::
Ethical Statements::
Registration::
Site Facilities::
Contact us::
::
Indexed by
    
..
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
Copyright Policies

 

AWT IMAGE

 

..
Open Access Policy

This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

..
:: Volume 6 - The Spring Supplement of Shefaye Khatam 1 - ::
Shefaye Khatam 2018, 6 - The Spring Supplement of Shefaye Khatam 1 -: 19-19 Back to browse issues page
O19: Advances in the Treatment and Limitations of Cell Therapy in Neurodegenerative Diseases
Karim Nikkhah *
Department of Neurology, Mashhad University of Medical Sciences, Mashhad, Iran , Nickk@mums.ac.ir
Abstract:   (3208 Views)

Neurodegenerative diseases are the hereditary and sporadic diseases which are characterized by progressive neuronal loss of the nervous system and are emerging as the leading cause of death, disabilities, and a socioeconomic burden due to an increase in life expectancy. There are many neurodegenerative diseases including Alzheimer’s disease, Parkinson’s, disease, amyotrophic lateral sclerosis, Huntington’s disease, and multiple sclerosis but There are no effective treatments or cures to halt the progression of any of these diseases. Stem cell-based therapy has become the alternative option to treat neurodegenerative diseases. There are several types of stem cells utilized;

1- Embryonic stem cells, induced pluripotent stem cells, and

2- Adult stem cell (mesenchymal stem cells and neural progenitor cells).

In this review, we summarize recent advances in the treatments and the limitations of various stem cell technologies. So, we focus on clinical trials of stem cell therapies for major neurodegenerative diseases especially multiple sclerosis.

Keywords: Stem Cells, Neurodegenerative Diseases, Progressive Neuronal Loss
Full-Text [PDF 232 kb]   (1136 Downloads)    
Type of Study: Review --- Open Access, CC-BY-NC | Subject: Basic research in Neuroscience


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Nikkhah K. O19: Advances in the Treatment and Limitations of Cell Therapy in Neurodegenerative Diseases. Shefaye Khatam 2018; 6 (S1) :19-19
URL: http://shefayekhatam.ir/article-1-1543-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 6 - The Spring Supplement of Shefaye Khatam 1 - Back to browse issues page
مجله علوم اعصاب شفای خاتم The Neuroscience Journal of Shefaye Khatam
Persian site map - English site map - Created in 0.07 seconds with 45 queries by YEKTAWEB 4710